» Articles » PMID: 32038105

Carbon Flux As a Measure of Prostate Cancer Aggressiveness: [C]-Acetate PET/CT

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2020 Feb 11
PMID 32038105
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

: Dynamic [C]-acetate positron emission tomography (PET) can be used to study tissue perfusion and carbon flux simultaneously. In this study, the feasibility of the quantification of prostate cancer aggressiveness using parametric methods assessing [C]-acetate kinetics was investigated in prostate cancer subjects. The underlying uptake mechanism correlated with [C]-acetate influx and efflux measured in real-time in vitro in cell culture. : Twenty-one patients with newly diagnosed low-to-moderate risk prostate cancer underwent magnetic resonance imaging (MRI) and dynamic [C]-acetate PET/CT examinations of the pelvis. Parametric images of K (extraction × perfusion), k (oxidative metabolism) and V (=K/k, anabolic metabolism defined as carbon retention) were constructed using a one-tissue compartment model with an arterial input function derived from pelvic arteries. Regions of interest (ROIs) of the largest cancer lesion in each patient and normal prostate tissue were drawn using information from MRI (T2 and DWI images), biopsy results, and post-surgical histopathology of whole prostate sections (n=7). In vitro kinetics of [C]-acetate were studied on DU145 and PC3 cell lines using LigandTracer White equipment for the measurement of the radioactivity uptake in real-time at 37°C. : Mean prostate specific antigen (PSA) was 8.33±3.92 ng/mL and median Gleason Sum 6 (range 5-7). K, V and standardized uptake values (SUVs) were significantly higher in cancerous prostate tissues compared to normal ones for all patients (p<0.001), while k was not (p=0.26). PSA values correlated to early SUVs (r=0.50, p=0.02) and K (r=0.48, p=0.03). Early and late SUVs correlated to V (r>0.76, p<0.001) and K (r>0.64, p<0.005). In vitro studies demonstrated higher extraction and retention (p<0.01) of [C]-acetate in the more aggressive PC3 cells. : Parametric images could be used to visualize the [C]-acetate kinetics of the prostate cancer exhibiting elevated extraction associated with the cancer aggressiveness. The influx rate of [C]-acetate studied in cell culture also showed dependence on the cancer aggressiveness associated with elevated lipogenesis. Dynamic [C]-acetate/PET demonstrated potential for prostate cancer aggressiveness estimation using parametric-based K and V values.

Citing Articles

Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness.

Jochumsen M, Sorensen J, Tolbod L, Pedersen B, Frokiaer J, Borre M EJNMMI Res. 2021; 11(1):12.

PMID: 33559792 PMC: 7873172. DOI: 10.1186/s13550-021-00757-y.


Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na/K-ATPase-density.

Jochumsen M, Sorensen J, Pedersen B, Nyengaard J, Krag S, Frokiaer J Eur J Nucl Med Mol Imaging. 2020; 48(2):532-542.

PMID: 32808078 PMC: 7835182. DOI: 10.1007/s00259-020-04998-2.

References
1.
Hegde J, Mulkern R, Panych L, Fennessy F, Fedorov A, Maier S . Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013; 37(5):1035-54. PMC: 3741996. DOI: 10.1002/jmri.23860. View

2.
Gropler R, Siegel B, Geltman E . Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med. 1991; 32(2):245-51. View

3.
Ristow M . Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care. 2006; 9(4):339-45. DOI: 10.1097/01.mco.0000232892.43921.98. View

4.
Vavere A, Kridel S, Wheeler F, Lewis J . 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008; 49(2):327-34. DOI: 10.2967/jnumed.107.046672. View

5.
Hansson N, Sorensen J, Harms H, Kim W, Nielsen R, Tolbod L . Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure. J Am Heart Assoc. 2017; 6(2). PMC: 5523773. DOI: 10.1161/JAHA.116.004810. View